This FDA InspectorProfile is a report of relevant audit-related information on Michael Klapal, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Human Drugs.
This InspectorProfile report is updated through and lists Michael Klapal's inspections in 6 countries: United States, Australia, Ireland, Canada, Germany, and India.
FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Michael Klapal's inspection information so that you can mitigate investigator-related risks.
Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Michael Klapal.
Note: The EIR and 483 documents are sold separately.